These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 4602088)
21. Another look at immunologic surveillance. Schwartz RS N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290 [No Abstract] [Full Text] [Related]
22. Immunosuppressive drugs used in clinical renal transplantation. Chatterjee SN Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101 [No Abstract] [Full Text] [Related]
23. Renal transplantation in infants and small children. Lawson RK; Campbell RA; Hodges CV Transplant Proc; 1971 Mar; 3(1):358-60. PubMed ID: 4937905 [No Abstract] [Full Text] [Related]
24. Proceedings: The effect of immunosuppression on cancer. Penn I; Starzl TE Proc Natl Cancer Conf; 1972; 7():425-36. PubMed ID: 4587653 [No Abstract] [Full Text] [Related]
25. Transplantation antigens and viral carcinogenesis. Haughton G; Nash DR Prog Med Virol; 1969; 11():248-306. PubMed ID: 4906871 [No Abstract] [Full Text] [Related]
26. Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts. MacDonald AS; Alexander JL; Busch GJ; Murray JE Surg Forum; 1969; 20():306-7. PubMed ID: 4192215 [No Abstract] [Full Text] [Related]
27. Complications of immunosuppression. Penn I Minerva Chir; 1971 Jul; 26(13):718-20. PubMed ID: 5567243 [No Abstract] [Full Text] [Related]
28. Malignancy as a complication of immunosuppressive therapy. Leibowitz S; Schwartz RS Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004 [No Abstract] [Full Text] [Related]
29. [Hybridization of transformed cells with lymphocytes as 1 of the probable causes of the progression leading to the development of metastatic malignant cells]. Mekler LB Vestn Akad Med Nauk SSSR; 1971; 26(8):80-9. PubMed ID: 4944404 [No Abstract] [Full Text] [Related]
30. Alteration of the homograft response as a determinant of carcinogenicity. Rubin BA Prog Exp Tumor Res; 1971; 14():138-95. PubMed ID: 4331010 [No Abstract] [Full Text] [Related]
32. Immunosuppression in organ transplantation: past, present, and future. Bach JF Transplant Proc; 1980 Dec; 12(4):588-90. PubMed ID: 7010718 [No Abstract] [Full Text] [Related]
33. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man]. Tilz GP Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374 [No Abstract] [Full Text] [Related]
34. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy. Guerin C; Pozzetto B; Genin C; Berthoux FC; Gaudin OG Nephrol Dial Transplant; 1988; 3(1):77-80. PubMed ID: 2837679 [TBL] [Abstract][Full Text] [Related]
35. [Immunosuppression in cancer--depression of immunological function in the host from initiation to neoplasm-bearing state]. Kitagawa M Nihon Rinsho; 1970 Jul; 28(7):1863-8. PubMed ID: 4918413 [No Abstract] [Full Text] [Related]
37. Carcinogenic action of anticancer drugs with special reference to immunosuppression. Schmähl D Cancer; 1977 Oct; 40(4 Suppl):1927-9. PubMed ID: 332335 [TBL] [Abstract][Full Text] [Related]
38. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients]. Galvão MM; Mendes NF; Ramos OL; Sabbaga E Rev Bras Pesqui Med Biol; 1972; 5(5):251-8. PubMed ID: 4573042 [No Abstract] [Full Text] [Related]
39. CADAVERIC RENAL HOMOTRANSPLANTATION WITH INADVERTENT TRANSPLANTATION OF CARCINOMA. MARTIN DC; RUBINI M; ROSEN VJ JAMA; 1965 May; 192():752-4. PubMed ID: 14285706 [No Abstract] [Full Text] [Related]
40. Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin. Gruber SA; Pescovitz M; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Elick B; Fryd DS Transplant Proc; 1987 Feb; 19(1 Pt 2):1815-6. PubMed ID: 3079041 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]